hypertensive disorders of pregnancy

in review 7 min read Updated 2026-10-15
hypertensive disorders of pregnancy

BP ≥140/90 in pregnancy = treat (SOGC 2022), target DBP 85. ≥160/110 = emergency — treat within 60 min to prevent stroke. Preeclampsia = new/worsening HTN + proteinuria or any adverse condition — proteinuria not required. MgSO₄ is seizure prophylaxis, not an antihypertensive. Delivery is definitive but BP peaks day 3–6 postpartum. Aspirin + exercise prevent it.

acute severe hypertension (≥160/110)

Confirm (repeat in 15 min) → treat within 60 min, antepartum or postpartum. Severe systolic alone suffices. Target: out of severe range, then DBP ~85; avoid precipitous drops (uteroplacental perfusion). If already on a daily agent, use a drug from a different class.

drugT0thenmax / caution
nifedipine capsule PO5–10 mg10 mg q30–60 min (at 30, 90, 150 min)swallow whole — don’t bite or puncture; headache, tachycardia
labetalol IV bolus10–20 mg20–40 mg at 30 min, then 40–80 mg q30 minmax 300 mg per course; avoid uncontrolled asthma, HF
labetalol IV infusion0.5–2 mg/mintitrateneonatal bradycardia/hypoglycaemia → newborn glucose screen
labetalol PO200 mg200 mg q1h × 2 morecontraindicated in uncontrolled asthma, HF
hydralazine IV5 mg5–10 mg q30 minmax 20 mg; hypotension, maternal/foetal tachycardia
methyldopa PO1000 mg—slow onset; often needs a second agent
  • Reassess 30 min after IV agents or nifedipine; 60 min after other oral agents
  • Uncontrolled after ~3 h → switch class (after nifedipine/hydralazine → oral labetalol or methyldopa)
  • Once controlled → routine oral maintenance (chronic hypertension in pregnancy)
  • Severe BP = MgSO₄ indication — give both (magnesium sulfate); Mg isn’t an antihypertensive
  • Pulmonary oedema → hydralazine/nitrate ± furosemide, not labetalol
  • Labour fluids ~80 mL/h total (↓ pulmonary oedema, no ↑ AKI); oliguria → assess volume, don’t reflexively bolus
  • Admit if severe HTN or any adverse condition; no bed rest
nifedipine XL ≠ capsule

XL is maintenance; the immediate-release capsule (swallowed whole) is the acute agent. Formulation errors are common.


classification and diagnosis

typedefinition
pre-existing (chronic)before pregnancy or <20 wk — see chronic hypertension in pregnancy
gestationalnew ≥20 wk, no adverse conditions
preeclampsianew/worsening HTN + ≥1 of: proteinuria, adverse condition, severe complication
superimposed preeclampsiapreeclampsia on chronic HTN
  • HTN: office ≥140/90 (average of ≥2 readings, 15 min apart); ABPM/home ≥135/85
  • Proteinuria: uPCR ≥30 mg/mmol, uACR ≥8 mg/mmol, ≥0.3 g/24 h, or ≥2+ dipstick (dipstick = screen only)
  • HELLP and eclampsia can occur with normal BP or before proteinuria
  • Uric acid: not a diagnostic test; sFlt-1:PlGF / PlGF where available (assay-specific)

SOGC adverse conditions vs severe complications

systemadverse condition → monitor, plan deliverysevere complication → deliver regardless of GA + MgSO₄
CNSsevere headache, visual symptomseclampsia, PRES, cortical blindness or retinal detachment, GCS <13, stroke/TIA/RIND
cardiorespiratorychest pain, dyspnoea, SpO₂ <97%uncontrolled severe HTN >12 h on 3 agents, SpO₂ <90%, pulmonary oedema, inotropes, MI
haematologicallow plateletsplt <50, transfusion of any blood product
renalrising CrAKI (Cr >150 µmol/L, no prior CKD), new dialysis indication
hepaticRUQ/epigastric pain, ↑AST/ALTINR >2 without DIC/warfarin, hepatic haematoma/rupture
uteroplacentalFGR, oligohydramnios, absent/reversed umbilical EDF, abnormal NST/CTG, angiogenic imbalance (e.g. sFlt-1:PlGF >85)abruption with maternal/foetal compromise, reversed ductus venosus a-wave, foetal death

Workup: SpO₂, plt, Cr, AST/ALT (SOGC minimum) + film, LDH, bilirubin, uPCR; INR/fibrinogen if plt low or severe. Repeat at least twice weekly. Trends > single values. Once proteinuria criteria are met, don’t repeat it.


delivery

Placenta out = definitive. Decision with obstetrics; involve anaesthesia, paediatrics.

scenariotiming
severe complication (table above) or foetal compromisedeliver now, regardless of GA
preeclampsia <34 wkexpectant only in a centre able to care for very preterm infants
preeclampsia 34⁺⁰–35⁺⁶ wkdiscuss delivery (↓ maternal, ↑ neonatal risk)
preeclampsia 36⁺⁰–36⁺⁶ wkconsider delivery
preeclampsia ≥37 wkdeliver
gestational / chronic HTN, no preeclampsiaoffer at 38⁺⁰–39⁺⁶ wk; advise from 40⁺⁰ wk
  • Betamethasone 12 mg IM q24h × 2 if ≤34⁺⁶ wk and delivery likely within 7 d — don’t delay indicated delivery to complete it
  • Steroids to treat HELLP: not recommended (transient lab improvement, no outcome benefit)
  • Platelet transfusion: <20 before vaginal, <50 before caesarean, or any time with active bleeding/rapid fall/coagulopathy
  • Preeclampsia ≠ indication for caesarean
  • Neuraxial: plt ≥75 typically acceptable without coagulopathy (anaesthesia-specific) — see haematology in pregnancy

postpartum

  • BP peaks day 3–7 (vasoconstriction returns, angiogenic factors persist); up to ~25% have postpartum HTN
  • Eclampsia, stroke, and de novo preeclampsia occur after discharge — mostly within 2 wk
  • BP at least twice in the first 2 wk (ACOG: by day 3–10); home BP monitoring
  • New/worsening HTN or symptoms postpartum → full preeclampsia workup
  • Breastfeeding (SOGC): labetalol, methyldopa, nifedipine, enalapril, captopril (ACEi fine postpartum)
  • Severe postpartum BP → same acute treatment + MgSO₄ if neuro symptoms
persistent or late postpartum preeclampsia — think retained products

Retained placental tissue can sustain the angiogenic imbalance → persistent/worsening preeclampsia, HELLP, or late eclampsia. Pelvic US ± obstetric review; evacuation if RPOC present. Evidence = case series, but cheap to exclude.


prevention

interventionwhodetail (SOGC 2022)
exerciseall (strong recommendation)≥140 min/wk moderate intensity → ~25% ↓ gestational HTN and preeclampsia
aspirin 81 or 162 mg qhs≥1 high-risk or ≥2 moderate-risk factorsbefore 16 wk, stop by 36 wk; SOGC: 81 or 162 mg, individualise — consider >81 mg; not for others
calciumdietary intake <900 mg/d≥500 mg/d supplement
diet + exerciseoverweight/obese at increased risk↓ calories, low glycaemic index
vitamin D above standard dose—not recommended
  • High risk (any 1): prior preeclampsia, BMI >30, chronic HTN, pregestational DM, CKD, SLE/APS, ART
  • Moderate risk (≥2): nulliparity, multifetal pregnancy, age >40, prior abruption, stillbirth, or FGR
  • Where available: 11–14 wk screening combining clinical factors + uterine artery PI + PlGF (FMF model)
  • GDM alone ≠ aspirin indication
  • Treat OSA (CPAP) and optimise BP/glycaemia/CKD pre-conception
  • Aspirin after placental disease is established doesn’t reverse it — timing matters
exercise is under-prescribed

SOGC: at least 140 min/wk of moderate-intensity activity (raises HR; can talk, can’t sing — brisk walking, water aerobics, stationary cycling, resistance training, gardening) → ~25% lower odds of gestational HTN and preeclampsia (also ↓ GDM). Canadian physical activity guideline: 150 min/wk over ≥3 days. Absolute contraindications include placenta praevia after 28 wk, preeclampsia, uncontrolled HTN, ruptured membranes, preterm labour.


long-term cardiovascular risk

  • Lifelong risk enhancer: ~4× chronic HTN, ~2× IHD and stroke (Bellamy, BMJ. 2007); ↑ HF, T2DM, CKD — highest after early-onset/severe preeclampsia
  • Recurrence ~1 in 6; ~25% if prior onset <34 wk, ~50% if <28 wk → aspirin from 12–16 wk next time
  • BP/labs normalise by 6 wk–3 months (up to 12); HTN persisting >6–12 months → secondary HTN workup
  • 6-wk visit: counsel on recurrence and CV risk; screen BP, lipids, glucose, weight; avoid interpregnancy weight gain
  • No statin while breastfeeding — lipids inform later risk
obstetrics → primary care handover

Record HDP as a diagnosis in the discharge summary — postpartum attendance alone doesn’t trigger CV prevention.


evidence

  • CHIPS (2015) — tight (DBP 85) vs less-tight (DBP 100): no difference in perinatal outcome; less-tight → more severe maternal HTN (41% vs 28%)
  • ASPRE (2017) — aspirin 150 mg qhs from 11–14 wk in screen-positive singletons: preterm preeclampsia 1.6% vs 4.3%
  • Davenport, Br J Sports Med. 2018 — exercise: gestational HTN OR 0.61, preeclampsia OR 0.59

Prepared 2026-10-15. Not yet verified — check every number against the sources.

Key references

+2 more sources

Suggest a correction hypertensive disorders of pregnancy